Analysis of the mom1 modifier of intestinal neoplasia in mice

Experimental Lung Research

Volumn 24, Issue 4, 1998, Pages 437-453

  Gould, Karen A ^a,b   Dove, William F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adenomatous polyposis coli (Apc); Intestinal tumors; Mice; Modifier of Min 1 (Mom1); Multiple intestinal neoplasia (Min); Quantitative trait locus

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GERM LINE; INBRED STRAIN; INTESTINE CANCER; INTESTINE EPITHELIUM; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT;

EID: 0031832644     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.3109/01902149809087379     Document Type: Conference Paper

References (62)

1. Cheng H, Leblond CP. Origin, differentiation, and renewal of the four main epithelial cell types in the mouse small intestines, V: unitarian theory of the origin of the four epithelial cell types. Am J Anat. 1974;141:537-562.
2. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties: lessons for and from the crypt. Development. 1990;110:1001-1020.
3. Kirkland S. Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium. Cancer. 1987;61:1359-1363.
4. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.
5. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorige -nesis. Nature. 1992;359:235-237.
6. Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA. 1993;90:2846-2850.
7. Bourne HR. Consider the coiled coil. Nature. 1991;351:188-190.
8. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991;66:589-600.
9. Kinzler KW, Nilbert MC, Su L-K, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661-665.
10. Joslyn G, Richardson DS, White R, Alber T. Dimer formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sci USA. 1993;90:11109-11113.
11. Su L-K, Johnson KA, Smith KJ, Hill DE, Vogelstein B, Kinzler KW. Association between wild type and mutant APC gene product. Cancer Res. 1993;53:2728-2731.
12. Rubinfeld B, Souza B, Albert I, et al. Association of APC gene product with β-catenin. Science. 1993;262:1731-1734.
13. Su L-K, Vogelstein B, Kinzler KW. Association of APC tumor suppressor protein with catenins. Science. 1993;262:1734-1737.
14. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science. 1996;275:1784-1787.
15. Morin PJ, Sparks AB, Korinek V, et al. Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC. Science. 1996;275:1787-1790.
16. Shoemaker AR, Gould KA, Luongo C, Moser AR, Dove WF. Studies of ncoplasia in the Min mouse. Biochim Biophys Acta. 1996;1332:f25-f48.
17. Matsumine A, Ogai A, Senda T, et al. Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science. 1996;272:1020-1023.
18. Woods DF, Bryant PJ. The discs-large tumor suppressor gene of Drosophila encodes a guanylatc kinase homolog localized at septate junctions. Cell. 1995;66:451-464.
19. Munemitsu S, Souza B, Müller O, Albert I, Rubinfeld B, Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res. 1994;54:3676-3681.
20. Smith KJ, Levy DB, Maupin P, Pollard TD, Vogelstein B, Kinzler KW. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res. 1994;54:3672-3675.
21. Nishisho I, Nakamure Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991;253:665-669.
22. Miyoshi Y, Nagase H, Ando H, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the A PC gene. Hum Mol Genet. 1992;1:229-233.
23. Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat. 1993;2:425-434.
24. Leppert M, Burt R, Hughes JP, et al. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med. 1990;322:904-908.
25. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell. 1993;75:1 -20.
26. Olschwang S, Tiret A, Laurent-Puig P, Muleris M, Parc R, Thomas G. Restriction of ocular fundus lesions to a specific subgroup of APC. mutations in adenomatous polyposis coli patients. Cell. 1993;75:959-968.
27. Dobbie Z, Spycher M, Mary J-L, et al. Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. J Med Genet. 1996;33:274-280.
28. Caspari R, Olschwang S, Friedl W, et al. Familial adenomatous polyposis: desmoid tumours and lack of opthalmic lesions (CHRPE) associated with APC mutations beyond codon, 1444. Hum Mol Genet. 1995;4:337-340.
29. Paul P, Letteboer T, Gelbert L, Groden J, White R, Coppes MJ. Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis. Hum Mol Genet. 1993;2:925-931.
30. Tomlinson IPM, Neale K, Talbot IC, et al. A modifying locus for familial adenomatous polyposis may be present on chromosome lp35-p36. J Med Genet. 1996;33:268-273.
31. Leister I, Weith A, Brüderlein S, et al. Human colorectal cancer: high frequency of deletions at chromosome lp35. Cancer Res. 1990;50:7232-7235.
32. Moser AR, Pitot HC, Dove WF. A dominant mutation that pedisposes to multiple intestinal neoplasia in the mouse. Science. 1990;247:322-324.
33. Su L-K, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 1992;256:688-670.
34. Luongo C, Gould KA, Su LK, et al. Genomics. 1993;15:3-8.
35. Moser AR, Shoemaker AR, Connelly CS, et al. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev. Dynamics. 1995;203:422-433.
36. Moser AR, Dove WF, Roth KA, Gordon, JI. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol. 1992;116:1517-1526.
37. Novelli MR, Williamson JA, Tomlinson IP, et al. Polyclonal origin of colonie adenomas in an XO/XY patient with FAP. Science. 1996;272:1187-1190.
38. + from all tumor lineages. Proc Natl Acad Sci USA. 1997;94:13927-13931.
39. + in intestinal adenomas from Min mice. Cancer Res. 1994;54:5947-5952.
40. Luongo C, Dove WF. Somatic genetics events linked to the Apc locus in intestinal adenomas of the Min mouse. Genes, Chrom Cancer. 1996;17:194-198.
41. Min/+ mice: Apc silencing versus dominant enhancement of Apc allele loss. Submitted.
42. Dove WF, Gould KA, Luongo C, Moser A, Shoemaker AR. Emergent issues in the genetics of intestinal neoplasia. Cancer Surveys. 1995;25:335-355.
43. Shoemaker AR, Moser AR, Dove WF. N-Ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effect on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res. 1995;55:4479-4485.
44. Dove WF, Luongo C, Connelly CS, et al. The adenomatous polyposis gene of the mouse in development and neoplasia. In: Cold Spring Harbor Symposia on Quantitative Biology: The Molecular Genetics of Cancer. Cold Spring Harbor: Cold Spring Harbor Press; 1994:501-508.
45. Dietrich WF, Lander ES, Smith J S, et al. Genetic identification of Mom1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell. 1993;75:631-639.
46. Gould KA, Luongo C, Moser AR, et al. Genetic evaluation of candidates genes for the Mom1 modifier of intestinal neoplasia in mice. Genetics. 1996;144:1777-1785.
47. Gould KA, Dietrich WF, Borenstein N, Lander ES, Dove WF. Mom1 is semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Genetics. 1996;144:1769-1777.
48. Lande R, Thompson R. Efficiency of marker-assisted selection in the improvement of quantitative traits. Genetics. 1989;124:743-756.
49. Hillel J, Schaap T, Haberfeld A, et al. DNA fingerprints applied to gene introgression in breeding programs. Genetics. 1989;124:783-789.
50. Hospital F, Chevalet C, Mulsant P. Using markers in gene introgression breeding programs. Genetics. 1992;132:1199-1210.
51. Min-induced intestinal neoplasia. Cell. 1995;81:957-966.
52. Mulherkar R, Desai SJ, Rao RS, Wagle AS, Deo MG. Expression of enhancing factor gene and its localization in mouse tissues. Histochemistry. 1991;96:367-370.
53. 2. J Clin Invest. 1995;95:603-610.
54. Frankel W. Taking stock of complex trait genetics in mice. Trends Genet. 1995;11:471-477.
55. rap1. Cell. 1991;65:1033-1042.
56. 2 genes are linked and map to homologous chromosome regions in mouse and human. Genomics. 1996;32:328-333.
57. Cormier RT, Hong K, Halberg RB, et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nature Genet. 1997;17:88-91.
58. Boolbol SK, Dannenberg AJ, Chadburn A, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 1996;56:2556-2560.
59. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 1996;56:710-714.
60. Gould KA, Dove WF. Action of Min and Mom1 in ectopic intestinal grafts. Cell Growth and Differ. 1996;7:1361-1368.
61. 2. Biochim Biophys Acta. 1993;117:217-231.
62. Gould KA, Dove WF. Localized Action of Min and Mom1 in intestinal neoplasia. Proc Natl Acad Sci USA. 1997;94:5848-5853.